liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
Karolinska Institute, Sweden; University Hospital, Sweden.
University of N Carolina, NC 27599 USA.
Karolinska Institute, Sweden; University Hospital, Sweden.
Karolinska Institute, Sweden; University Hospital, Sweden.
Show others and affiliations
2015 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 26, no 1, 81-88 p.Article in journal (Refereed) Published
Abstract [en]

We and others have recently shown that tumor characteristics are altered throughout tumor progression. These findings emphasize the need for re-examination of tumor characteristics at relapse and have led to recommendations from ESMO and the Swedish Breast Cancer group. Here, we aim to determine whether tumor characteristics and molecular subtypes in breast cancer metastases confer clinically relevant prognostic information for patients. The translational aspect of the Swedish multicenter randomized trial called TEX included 111 patients with at least one biopsy from a morphologically confirmed locoregional or distant breast cancer metastasis diagnosed from December 2002 until June 2007. All patients had detailed clinical information, complete follow-up, and metastasis gene expression information (Affymetrix array GPL10379). We assessed the previously published gene expression modules describing biological processes [proliferation, apoptosis, human epidermal receptor 2 (HER2) and estrogen (ER) signaling, tumor invasion, immune response, and angiogenesis] and pathways (Ras, MAPK, PTEN, AKT-MTOR, PI3KCA, IGF1, Src, Myc, E2F3, and beta-catenin) and the intrinsic subtypes (PAM50). Furthermore, by contrasting genes expressed in the metastases in relation to survival, we derived a poor metastasis survival signature. A significant reduction in post-relapse breast cancer-specific survival was associated with low-ER receptor signaling and apoptosis gene module scores, and high AKT-MTOR, Ras, and beta-catenin module scores. Similarly, intrinsic subtyping of the metastases provided statistically significant post-relapse survival information with the worst survival outcome in the basal-like [hazard ratio (HR) 3.7; 95% confidence interval (CI) 1.3-10.9] and HER2-enriched (HR 4.4; 95% CI 1.5-12.8) subtypes compared with the luminal A subtype. Overall, 25% of the metastases were basal-like, 32% HER2-enriched, 10% luminal A, 28% luminal B, and 5% normal-like. We show that tumor characteristics and molecular subtypes of breast cancer metastases significantly influence post-relapse patient survival, emphasizing that molecular investigations at relapse provide prognostic and clinically relevant information.

Place, publisher, year, edition, pages
Oxford University Press (OUP): Policy A1 - Oxford Open Option F , 2015. Vol. 26, no 1, 81-88 p.
Keyword [en]
breast cancer metastases; metastasis characteristics; TEX randomized trial; gene expression; gene modules; biopsy at relapse
National Category
Clinical Medicine
URN: urn:nbn:se:liu:diva-114243DOI: 10.1093/annonc/mdu498ISI: 000347416300013PubMedID: 25361981OAI: diva2:788702

Funding Agencies|Swedish Research Council [524-2011-6857, 521-2014-2057]; Swedish Research Council for Health, Working life and Welfare, FORTE [2014-1962]; Swedish Cancer Society; Cancer Society in Stockholm; King Gustaf V Jubilee Foundation; Swedish Breast Cancer Association (BRO); Swedish Research Council; Bristol-Myers Squibb Sweden AB; Pfizer Sweden AB; Roche Sweden AB; NCI Breast SPORE program [P50-CA58223-09A1]; Breast Cancer Research Foundation (CMP)

Available from: 2015-02-16 Created: 2015-02-16 Last updated: 2015-02-25

Open Access in DiVA

fulltext(667 kB)113 downloads
File information
File name FULLTEXT01.pdfFile size 667 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Walz, Thomas
By organisation
Division of Clinical SciencesFaculty of Health SciencesDepartment of Oncology
In the same journal
Annals of Oncology
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
Total: 113 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 90 hits
ReferencesLink to record
Permanent link

Direct link